risperidone has been researched along with Blepharoptosis in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Blepharoptosis: Drooping of the upper lid due to deficient development or paralysis of the levator palpebrae muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aripiprazole did not inhibit physostigmine- or norepinephrine-induced lethality in rats." | 1.32 | Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile. ( Altar, CA; Burris, KD; Hirose, T; Kikuchi, T; Kitagawa, H; Miwa, T; Nabeshima, T; Uwahodo, Y; Yamada, S, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirose, T | 1 |
| Uwahodo, Y | 1 |
| Yamada, S | 1 |
| Miwa, T | 1 |
| Kikuchi, T | 1 |
| Kitagawa, H | 1 |
| Burris, KD | 1 |
| Altar, CA | 1 |
| Nabeshima, T | 1 |
1 other study available for risperidone and Blepharoptosis
| Article | Year |
|---|---|
Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blepharoptosis; Catalepsy; Dihydroxyph | 2004 |